AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 90 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $78,000 | -71.1% | 108,193 | -9.4% | 0.00% | – |
| Q4 2021 | $270,000 | -18.7% | 119,429 | +3.7% | 0.00% | – |
| Q3 2021 | $332,000 | -20.2% | 115,185 | +5.0% | 0.00% | – |
| Q2 2021 | $416,000 | +10.3% | 109,729 | -1.3% | 0.00% | – |
| Q1 2021 | $377,000 | +12.2% | 111,218 | -7.4% | 0.00% | – |
| Q4 2020 | $336,000 | -69.6% | 120,123 | -72.8% | 0.00% | -100.0% |
| Q3 2020 | $1,107,000 | -70.5% | 441,126 | +59.9% | 0.00% | -66.7% |
| Q2 2020 | $3,747,000 | +108.6% | 275,948 | +16.5% | 0.00% | +50.0% |
| Q1 2020 | $1,796,000 | +256.3% | 236,902 | +196.3% | 0.00% | – |
| Q4 2019 | $504,000 | +180.0% | 79,952 | +72.9% | 0.00% | – |
| Q3 2019 | $180,000 | -75.1% | 46,231 | -69.1% | 0.00% | – |
| Q2 2019 | $723,000 | -9.3% | 149,633 | +53.3% | 0.00% | – |
| Q1 2019 | $797,000 | -16.8% | 97,592 | -43.7% | 0.00% | -100.0% |
| Q4 2018 | $958,000 | -82.4% | 173,269 | -71.9% | 0.00% | -50.0% |
| Q3 2018 | $5,439,000 | +78.2% | 616,337 | +101.4% | 0.00% | +100.0% |
| Q2 2018 | $3,052,000 | -30.6% | 306,074 | -33.7% | 0.00% | -50.0% |
| Q1 2018 | $4,396,000 | +83.0% | 461,445 | +185.5% | 0.00% | 0.0% |
| Q4 2017 | $2,402,000 | -42.2% | 161,640 | -23.6% | 0.00% | -33.3% |
| Q3 2017 | $4,158,000 | +5.2% | 211,440 | -23.2% | 0.00% | 0.0% |
| Q2 2017 | $3,953,000 | +1948.2% | 275,191 | +1201.7% | 0.00% | – |
| Q1 2017 | $193,000 | -24.0% | 21,141 | -14.0% | 0.00% | – |
| Q4 2016 | $254,000 | +103.2% | 24,572 | +76.6% | 0.00% | – |
| Q3 2016 | $125,000 | -38.1% | 13,910 | -48.9% | 0.00% | – |
| Q2 2016 | $202,000 | +17.4% | 27,195 | +41.7% | 0.00% | – |
| Q1 2016 | $172,000 | -33.8% | 19,194 | -5.4% | 0.00% | – |
| Q4 2015 | $260,000 | +66.7% | 20,291 | +23.8% | 0.00% | – |
| Q3 2015 | $156,000 | -91.1% | 16,393 | -90.4% | 0.00% | -100.0% |
| Q2 2015 | $1,761,000 | +3493.9% | 171,387 | +3780.2% | 0.00% | – |
| Q1 2015 | $49,000 | -57.4% | 4,417 | -55.7% | 0.00% | – |
| Q4 2014 | $115,000 | +11400.0% | 9,971 | +13748.6% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 72 | +84.6% | 0.00% | – |
| Q2 2014 | $1,000 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |